Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors

NCT00730223 is registered in ClinicalTrials.gov with Vanderbilt University as lead sponsor.

NCT NCT00730223
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00730223 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Genetic Determinants of the Metabolism of Non-nucleoside Reverse Transcriptase Inhibitors
Lead sponsor
Vanderbilt University
Phase
Phase 1
Overall status
Completed
Start date
March 31, 2004
Completion date
August 31, 2009
Enrollment
33 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hiv infections